Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Les Noe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
Managed Care Interface|December 3, 2004
The implications of poor medication persistence with treatment for overactive bladderLes Noe, Robyn Sneeringer, Bimal Patel, et al.
Current Medical Research and Opinion|April 22, 2008
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ERNorman Zinner, Les Noe, Lawrence Rasouliyan, et al.
The American Journal of Geriatric Pharmacotherapy|February 5, 2010
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysisNorman Zinner, Les Noe, Lawrence Rasouliyan, et al.
Clinical Therapeutics|July 22, 2008
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label studyJames F Donohue, Nicola A Hanania, Ronald L Ciubotaru, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
Managed Care Interface|December 3, 2004
The implications of poor medication persistence with treatment for overactive bladderLes Noe, Robyn Sneeringer, Bimal Patel, et al.
Current Medical Research and Opinion|April 22, 2008
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ERNorman Zinner, Les Noe, Lawrence Rasouliyan, et al.
The American Journal of Geriatric Pharmacotherapy|February 5, 2010
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysisNorman Zinner, Les Noe, Lawrence Rasouliyan, et al.
Clinical Therapeutics|July 22, 2008
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label studyJames F Donohue, Nicola A Hanania, Ronald L Ciubotaru, et al.
Pageof 1